Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Leases: 2019-2020

Historic Leases for Larimar Therapeutics (LRMR) over the last 2 years, with Sep 2020 value amounting to $4.1 million.

  • Larimar Therapeutics' Leases fell 42.92% to $4.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $4.1 million, marking a year-over-year decrease of 42.92%. This contributed to the annual value of $87,000 for FY2019, which is N/A change from last year.
  • Latest data reveals that Larimar Therapeutics reported Leases of $4.1 million as of Q3 2020, which was down 3.72% from $4.3 million recorded in Q2 2020.
  • Larimar Therapeutics' Leases' 5-year high stood at $7.3 million during Q2 2019, with a 5-year trough of $87,000 in Q4 2019.
  • For the 2-year period, Larimar Therapeutics' Leases averaged around $3.5 million, with its median value being $4.1 million (2020).
  • Data for Larimar Therapeutics' Leases shows a maximum YoY crashed of 54.70% (in 2020) over the last 5 years.
  • Over the past 2 years, Larimar Therapeutics' Leases (Quarterly) stood at $87,000 in 2019, then tumbled by 42.92% to $4.1 million in 2020.
  • Its last three reported values are $4.1 million in Q3 2020, $4.3 million for Q2 2020, and $400,000 during Q1 2020.